The GLP is committed to full transparency. Download and review our 2019 Annual Report

EU Parliament, bucking EU Commission, opposes authorization of five new GMOs

| October 7, 2016
european parliament
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The European Parliament opposed the European Commission plans to authorise five GMO products, maize Bt11, 1507 and MON810 (seeds and products), and a glyphosate-resistant cotton, in a vote on [Oct. 6]. MEPs reiterated their call for a reform of the EU’s GMO authorisation procedure.

. . . .

MEPs worry that maize Bt11 and maize 1507 could harm “non-target” species of butterflies and moths. They question the concept, introduced by the European Food Safety Authority (EFSA) of an “acceptable local mortality” of non-target lepidopteran species.

The EFSA assessment of maize MON 810 seeds lacks data, say MEPs, who point out that possible cross-contamination by an invasive plant carrying Bacillus thuringiensis (Bt) toxin, used as a pesticide, poses “major risks for farmers and the environment.”

Related article:  Bayer faces first glyphosate-cancer lawsuit in Australia as US plaintiff count tops 13,400

…MEPs point out that GMOs are now being authorised in the EU by the Commission, without the support of opinions of member state committees. This was supposed to be an exception to the usual decision-taking procedure, but has in fact become the norm.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Press release – MEPs oppose EU Commission plans to authorise five GMOs

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend